McKesson, Merck back Atropos Health’s $33M round to accelerate drug development with AI

Credit: VentureBeat made with Midjourney



Atropos Health raises $33 million in Series B funding to revolutionize healthcare with AI-powered clinical evidence generation, aiming to personalize medical decision-making and accelerate drug development.Read More



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Pin It on Pinterest